Saks Samuel R 4
4 · PDL BIOPHARMA, INC. · Filed Jun 24, 2019
Insider Transaction Report
Form 4
Saks Samuel R
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-20$3.00/sh+126,050$378,150→ 126,050 totalExercise: $3.00Exp: 2029-06-19→ Common stock (126,050 underlying)
Footnotes (1)
- [F1]The stock options shall vest on a monthly basis pro rata over the twelve (12) months following the grant date, provided that the recipient's continuous service has not terminated prior to the applicable vesting date.